Thus, decreased CES2 appears to be a causative factor in the progression of hepatic metabolic disease and suggests that strategies restoring CES2 activity may prove effective in the treatment of obesity-associated metabolic disease. This evidence concerns the gene CES2 and Other metabolic disease.